March 25, 2022 02:10 PM EDT
Pharma
Law

Mer­ck fi­nal­ly free from frac­ture law­suits over Fos­amax la­bel

Paul Schloesser

Associate Editor

Mer­ck is fi­nal­ly free from be­ing held li­able in more than 500 law­suits re­lat­ed to the safe­ty of its os­teo­poro­sis drug Fos­amax, end­ing a saga …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Deer­field wins fight to ac­quire Sin­gu­lar Ge­nomics, beat­ing out Tang Cap­i­tal’s Con­cen­tra

CMS ex­plains what went in­to its first round of drug price ne­go­ti­a­tions

Ver­tex gets 'van­za triple' ap­proval and Trikaf­ta ex­pan­sion — with boxed warn­ings

Three drug­mak­ers sue US over 340B dis­counts to STD clin­ics they al­lege don’t qual­i­fy

A service from the Financial Times